Levels, the health technology company known for pioneering continuous glucose insights for health-conscious consumers, today announced the availability of Stelo by Dexcom, the first FDA-cleared glucose biosensor available without a prescription in the United States, to its members. Stelo makes it easier than ever for health-conscious individuals to access 24/7 glucose insights, no prescription or diagnosis needed.
The launch builds on the momentum of the company’s latest offering, which introduced lab testing, registered dietitian coaching, and AI-powered habit tracking. With Stelo now fully available, Levels becomes the first health platform to offer both glucose biosensing technology and comprehensive health improvement tools in a single membership.
Stelo is built on the most accurate glucose monitoring technology from Dexcom—but is tailored for everyday wellness. By removing prescription barriers, Levels now brings metabolic feedback to a broader population curious about how food, stress, sleep, and movement affect their energy, cravings, and long-term health.
“We’ve spent the last six years building the most complete platform for metabolic health,” said Josh Clemente, co-founder and president of Levels. “With Stelo, we’re giving even more people the ability to tune into their body’s signals. It’s a powerful tool for building better habits, and it’s now easier to access than ever.”
Glucose biosensing data is becoming a standard tool in the modern health toolkit, but most offerings still cater to people managing chronic illness. Stelo fills a crucial gap by delivering accessible, consumer-friendly insights designed for proactive health.
With Stelo, members can:
- Access a glucose biosensor without a prescription
- Pair their glucose data with personalized guidance inside the Levels app
- Track how meals, activity, stress, and sleep impact their body
- Get actionable insights to reduce crashes, stabilize energy, and support long-term goals
Available Now
Stelo is available to purchase with a Levels membership at levels.com, with no prescription required in the U.S.
For visuals and media assets, visit our digital press kit.
Levels helps members reach their health goals with lab tests, AI-powered food logging, habit tracking, and custom insights. Members can add tools like glucose biosensors, dietitian coaching, and expanded lab tests for a more complete picture of their health. Levels is an a16z-backed health tech startup founded in 2019 that’s leveraging wearable biosensors and testing to provide feedback on how members can use diet and lifestyle choices to reach optimal health.
The Levels Advisory Board includes key thought leaders, clinicians, and researchers in metabolic health, including Ben Bikman, PhD; Dom D’Agostino, PhD; Dr. Sara Szal Gottfried; Dr. Robert Lustig; Dr. Casey Means; Dr. David Perlmutter; and Dr. Terry Wahls.
Jack Taylor PR
